We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.3%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$38.5B
AUM Growth
+$4.48B
(+13%)
Cap. Flow
+$4.55B
Cap. Flow
% of AUM
11.82%
Top 10 Holdings %
Top 10 Hldgs %
13.89%
Holding
2,364
New
149
Increased
1,180
Reduced
895
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$275M |
| 2 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$221M |
| 3 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$193M |
| 4 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$188M |
| 5 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$230M |
| 2 |
Spectrum Brands
SPB
|
+$81.6M |
| 3 |
Chevron
CVX
|
+$79.8M |
| 4 |
Pfizer
PFE
|
+$66.7M |
| 5 |
K
Kellanova
K
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.09% |
| 2 | Consumer Discretionary | 10.38% |
| 3 | Technology | 9.81% |
| 4 | Consumer Staples | 7.93% |
| 5 | Communication Services | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRCL
401
DELISTED
Stericycle Inc
SRCL
| $21.3M | 0.06% |
158,904
+31,688
| +25% | +$4.34M |
|
402
ServiceNow
NOW
$102B
| $21.2M | 0.06% |
1,428,630
+438,240
| +44% | +$6.76M |
|
403
Newell Brands
NWL
$2.16B
| $21.2M | 0.06% |
515,455
+8,973
| +2% | +$360K |
|
|
ATW
404
DELISTED
Atwood Oceanics
ATW
| $21.1M | 0.05% |
799,333
-40,341
| -5% | -$1.24M |
|
|
POM
405
DELISTED
PEPCO HOLDINGS, INC.
POM
| $21.1M | 0.05% |
784,438
-67,808
| -8% | -$1.8M |
|
406
Gentex
GNTX
$4.88B
| $21.1M | 0.05% |
1,284,259
-328,651
| -20% | -$5.75M |
|
407
CDW
CDW
$17.1B
| $21.1M | 0.05% |
614,987
+127,369
| +26% | +$4.75M |
|
408
Norfolk Southern
NSC
$78.8B
| $21.1M | 0.05% |
241,086
+33,082
| +16% | +$3.22M |
|
409
Allstate
ALL
$66.9B
| $21M | 0.05% |
324,101
+29,694
| +10% | +$2.04M |
|
410
T. Rowe Price
TROW
$25B
| $21M | 0.05% |
270,371
+79,949
| +42% | +$6.45M |
|
|
CST
411
DELISTED
CST Brands, Inc.
CST
| $21M | 0.05% |
536,995
-55,141
| -9% | -$2.3M |
|
|
WR
412
DELISTED
Westar Energy Inc
WR
| $20.9M | 0.05% |
610,797
+102,211
| +20% | +$3.74M |
|
|
PBCT
413
DELISTED
People's United Financial Inc
PBCT
| $20.8M | 0.05% |
1,283,246
+193,514
| +18% | +$3.01M |
|
414
Telus
TU
$16B
| $20.8M | 0.05% |
1,205,868
-27,000
| -2% | -$463K |
|
|
LLL
415
DELISTED
L3 Technologies, Inc.
LLL
| $20.7M | 0.05% |
182,247
+46,797
| +35% | +$5.57M |
|
416
Bio-Rad Laboratories Class A
BIO
$8.42B
| $20.7M | 0.05% |
137,189
+5,874
| +4% | +$840K |
|
|
HCC
417
DELISTED
HCC INSURANCES HOLDINGS INC
HCC
| $20.6M | 0.05% |
268,714
-80,151
| -23% | -$4.99M |
|
|
GAP
418
The Gap Inc
GAP
$6.84B
| $20.6M | 0.05% |
539,841
+12,802
| +2% | +$506K |
|
419
Stellantis
STLA
$16.5B
| $20.6M | 0.05% |
2,174,297
+449,857
| +26% | +$4.61M |
|
|
WBC
420
DELISTED
WABCO HOLDINGS INC.
WBC
| $20.6M | 0.05% |
166,428
+51,690
| +45% | +$6.51M |
|
|
ELNK
421
DELISTED
EarthLink Holdings Corp.
ELNK
| $20.6M | 0.05% |
2,744,199
-263,901
| -9% | -$1.6M |
|
|
CHS
422
DELISTED
Chicos FAS, Inc.
CHS
| $20.5M | 0.05% |
1,235,682
-110,110
| -8% | -$1.88M |
|
423
Sherwin-Williams
SHW
$78.3B
| $20.5M | 0.05% |
224,007
-4,080
| -2% | -$387K |
|
424
Dillards
DDS
$8.87B
| $20.4M | 0.05% |
194,383
-5,470
| -3% | -$672K |
|
|
SIRO
425
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
| $20.4M | 0.05% |
203,250
-145,027
| -42% | -$13.9M |
|
Similar funds
DAM
First Trust Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, First Trust Advisors held 2,364 positions worth $38.5B, up 13% from $34B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
First Trust Advisors deployed $4.55B of net new capital in Q2 2015, opening 149 new positions and adding to 1,180 existing holdings. Its largest new stake was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Chevron, an estimated $79.8M trimmed.
- First Trust Advisors's largest Q2 2015 buy was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q2 2015, an estimated $275M increase.
- First Trust Advisors's biggest Q2 2015 reduction was Chevron, cutting an estimated $79.8M.
- First Trust Advisors fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $230M.
- First Trust Advisors's ten largest holdings make up 14% of its $38.5B portfolio in Q2 2015.
- First Trust Advisors opened 149 new positions and closed 134 in Q2 2015.
- First Trust Advisors's portfolio value rose 13% quarter-over-quarter to $38.5B.
Based on First Trust Advisors's 13F filing for Q2 2015, filed 4 Aug 2015.